Our FibroScan family of products
FibroScan is a pain-free, non-invasive examination of the liver, providing physicians with both liver stiffness and liver fat scores in a single 10-minute procedure. Our FibroScan family of products all come equipped to offer you the same capabilities and examination experience, allowing you the flexibility to choose the size and portability options that suit your needs best.
Unprecedented Mobility for Liver Assessment Efficiency
The FibroScan mini+ is our most portable system, weighing in just over 10lbs, our mini+ is the smallest addition to the FibroScan family of products for access to those who need it most.
Learn more
Innovation in Liver Disease Management
With its optional roll stand, big 15” touchscreen display, durable yet ergonomic design, the FibroScan Compact is a perfect liver assessment solution for any point-of-care setting.
Learn more
FDA Cleared
FibroScan is the first and only point of care device specifically developed and FDA-Cleared as an aid to the diagnosis and monitoring of adult patients with liver disease. The Shear wave speed stiffness generated by the FibroScan examination may be used as an aid to clinical management of pediatric patients with liver disease.
Learn more about FDA clearance
Deployed at Beth Israel
"FibroScan is the most effective and best screening test for the diagnosis of chronic liver disease"
Nezam Afdhal, MD
Beth Israel Deaconess Medical Center
Play Video
See how FibroScan is helping BIDMC
Current media
Diabetes Wake-Up Call: Liver Screening Tools Help Battle Obesity-Related Diseases
Join us in raising awareness about American Diabetes Association Diabetes Alert Day®, March 23, 2021 Every fourth Tuesday in March, Diabetes Alert Day represents a one-day “wake-up call” that brings…
Read More
Fatty Liver Disease Impacts Minority Populations: April 2021 is National Minority Health Month
Join Echosens in helping raise awareness about the importance of early detection of liver disease. (more…)
Read More
COVID-19 Impact: Higher Risks of Severity Among Obese and Chronic Liver Disease Patients
The COVID-19 pandemic has emerged as a complicated and pernicious disease. Recently, the Centers for Disease Control and Prevention (CDC) warns that adults of any age with certain underlying medical conditions are…
Read More
Contact a representative
In North America there are over 1200+ FibroScan systems in operation & we’re growing!
Speak to a Representative
